The multidru
g resistance proteins MRP1 and MRP2 are efflux transporters with broadsubstrate specificity, includin
g glutathione,
glucuronide, and sulfate conju
gates. In the presentstudy, the interaction of the dietary polyphenol curcumin with MRP1 and MRP2 and theinterplay between curcumin-dependent MRP inhibition and its
glutathione-dependent metabolism were investi
gated usin
g two transport model systems. In isolated membrane vesiclesof MRP1- and MRP2-expressin
g Sf9 cells, curcumin clearly inhibited both MRP1- and MRP2-mediated transport with IC
50 values of 15 and 5
ges/entities/m
gr.
gif">M, respectively. In intact monolayers ofMRP1 overexpressin
g Madin-Darby canine kidney (MDCKII-MRP1) cells, curcumin alsoinhibited MRP1-mediated activity, althou
gh with a 3-fold hi
gher IC
50 value than the oneobserved in the vesicle model. Interestin
gly, MRP2-mediated activity was hardly inhibited inintact monolayers of MRP2-overexpressin
g MDCKII (MDCKII-MRP2) cells upon exposure tocurcumin, whereas the IC
50 value in the vesicle incubations was 5
ges/entities/m
gr.
gif">M. The difference in extentof inhibition of the MRPs by curcumin in isolated vesicles as compared to intact cells, observedespecially for MRP2, was shown to be due to a swift metabolism of curcumin to two
glutathioneconju
gates in the MDCKII cells. Formation of both
glutathione conju
gates was about six timeshi
gher in the MDCKII-MRP2 cells as compared with the MDCKII-MRP1 cells, a phenomenonthat could be ascribed to the si
gnificantly lower
glutathione levels in the cell line. The effluxof both conju
gates, identified in the present study as mono
glutathionyl curcumin conju
gates,was demonstrated to be mediated by both MRP1 and MRP2. From dose-response curves with
Sf9 membrane vesicles,
glutathionylcurcumin conju
gates appeared to be less potent inhibitorsof MRP1 and MRP2 than their parent compound curcumin. In conclusion, curcumin clearlyinhibits both MRP1- and MRP2-mediated transport, but the
glutathione-dependent metabolismof curcumin plays a crucial role in the ultimate level of inhibition of MRP-mediated transportthat can be achieved in a cellular system. This complex interplay between MRP inhibitionand metabolism of MRP inhibitors, the latter affectin
g the ultimate potential of a compoundfor cellular MRP inhibition, may exist not only for a compound like curcumin but also formany other MRP inhibitors presently or previously developed on the basis of vesicle studies.